Renal Cell Carcinoma
Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma
A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Pazopanib as Adjuvant Therapy for Subjects With Localized or Locally Advanced RCC Following Nephrectomy
Investigator: Scott Tykodi, M.D., Ph.D.; Conditions: Renal Cell Carcinoma; Status: Recruiting; Study ID: NCT01235962
A Randomized, Controlled Phase III Study Investigating IMA901 Multipeptide Cancer Vaccine in Patients Receiving Sunitinib as First-line Therapy for Advanced/Metastatic Renal Cell Carcinoma
Investigator: Scott Tykodi, M.D., Ph.D.; Conditions: Metastatic Renal Cell Carcinoma; Status: Recruiting; Study ID: NCT01265901
EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study
Investigator: Fred Appelbaum, MD; Conditions: Renal Cancer; Solid Tumors; Status: Recruiting; Study ID: NCT01120249
Join Us On